Naratuximab emtansine
Naratuximab emtansine Uses, Dosage, Side Effects, Food Interaction and all others data.
Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).
| Trade Name | Naratuximab emtansine |
| Generic | Naratuximab emtansine |
| Naratuximab emtansine Other Names | Naratuximab emtansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Naratuximab emtansine
